Trial intelligence / Profile preview

[18F]MODAG-009 PET Imaging in Healthy Volunteers

NCT07617688Phase 1Recruiting

Sponsor
MODAG
Start
May 2026
Primary completion
May 2027
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of [18F]MODAG-009, sponsored by MODAG. Primary endpoint: Safety and Tolerability at 7 days. Started May 2026; status: recruiting.

02

Drugs

[18F]MODAG-009

Beyond the preview

Go deeper on NCT07617688.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07617688.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call